Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva

This study aims to identify clinical symptoms and outcomes, as well as response to anti-viral treatment in children living in Geneva, with influenza A/ H1N1 infection during the current pandemic.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Asthma Asthmatic Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Immunosuppressed Infections Lung Diseases Lung Diseases, Obstructive Nervous System Diseases Neuromuscular Diseases Orthomyxoviridae Infections RNA Virus Infections Respiratory Hypersensitivity Respiratory Tract Diseases Virus Diseases

Age range

Up to 16 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Children's Hospital of Geneva, HUG

Geneva, Canton of Geneva, 1211, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

suspicion of H1N1 infection

Exclusion criteria

Not available for a 30 days follow-up

Treatment and study plan

Primary outcomes

ABCB1 polymorphisms

Time frame: 6 months

ABCB1 gene polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia

Sponsors and collaborators

Lead sponsor

University Hospital, Geneva

Other

Registry information

Official study title

Evaluation of a New Virus(Influenza A H1N1/09) in Children: Epidemiology, Clinical Presentation and Outcome, and Response to Treatment

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2012
First posted: Dec 1, 2009
Registry last updated: Dec 11, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting